Therapy of Autoimmune Diseases with Antibody to Immune Response Gene Products or to T‐Cell Surface Markersa
Authors:
- 1 July 1986
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 475 (1) , 274-284
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.Journal of Experimental Medicine, 1985
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.Proceedings of the National Academy of Sciences, 1984
- Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies.Proceedings of the National Academy of Sciences, 1984
- Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.Journal of Experimental Medicine, 1983
- Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.Journal of Experimental Medicine, 1983
- Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibodyJournal of Neuroimmunology, 1983
- In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptorProceedings of the National Academy of Sciences, 1983
- Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies.Journal of Experimental Medicine, 1982
- In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.Journal of Experimental Medicine, 1981